Baseline of Pharmaceuticals

The Inside Story – Fattening Accounts or Customer Safety:

Few days ago, the world’s topmost pharmaceuticals manufacturer “Pfizer”– announced that it would cut down its 20% of total product costs in US. This step may is considered as a way to reduce costs thereby increasing profits.

Pfizer spokesman Paul Fitzhenry said that the after effect of this reduction may result in adverse for employees The job cuts will affect 2,200 employees at all levels of the drug giant’s sales operation, right from lower level to upper staff. While the latest workforce reduction is set to end layoffs in the U.S. sales sector, the rest of the company’s operations are still under review and could possibly experience cuts, Fitzhenry said.

Consequently, these job cuts should help Pfizer successfully reign in costs.

“The easier way to win is to have a pipeline (of new drugs in development), but until you have more sources of growth ahead

of you, cutting costs is the smart thing to do,” An optimistic and logical statement that came out of sources of Pfizer.

With 20 percent of its sales force now unemployed, Pfizer said it would still be able to maintain its sales operations with its 11,000 remaining employees. However, Pfizer could announce more cuts to further balance costs..

“I wouldn’t be surprised if this was just the first step, but just how low to go is a very tough question to answer,” he said. “I actually don’t think the industry knows how far they can cut.”

Pfizer’s profits have suffered recently after slow sales of older medications and failed attempts at launching newer drugs. A major contributor to the profits made so far being Viagra.

A recent study shows that recreational use of Viagra is growing rapidly in men under 45 years of age. From 1998 to 2002, the use of Viagra in men under forty-five tripled, says the study, which looked at 5 million insured American males. This Shows that Viagra is being used as a recreational drug, not as a drug to treat a medical condition. Thus, it belongs more in the category of pot, crack, heroin, or meth rather than being a medicinal pharmaceutical. This may add to Pfizer’s Profits.

But the big picture is at the background — the maker of Viagra earns profits regardless of how it’s used. And from where I

sit, I haven’t seen Pfizer working very hard to try to limit the sale of this drug to younger men for recreational use which forces us to think of company ethics and protocols. Right drugs by right people and customer safety being two of the ethics.

But instead, the company seems happy to sell the drug to all variety of sources. In the end these drugs do into the hands of youngsters who are not medically supposed to be in use of such drugs which in turn proves fatal. Generally youngsters make use of such things because of extremely poor health on the part of the younger generation today due to their mass consumption of junk foods, soft drinks, and food ingredients that deplete their nutrition and alter their libido. Lack of proper workouts and exercise also contributes to this a little.

The most alarming fact which contributes to this is that Pfizer is doing very little to restrict the use of such to a defined age groups only. But, since the major goal of every company is to make maximum profits Pfizer would rather find hard to take such harsh steps which may affect their sales and at the end gross profits.

A major fact is that Pfizer is also doing nothing to reduce Viagra spam that hit the E-mails of most of the users. The very true fact is that it seems to be in the financial interest of Pfizer since Pfizer generates profits from it anyway , regardless of who buys the product or how it’s sold,

The Inside Story is that pharmaceutical companies don’t care how their drugs are sold or who uses them, even if there’s no justified medical use whatsoever. They simply want to sell more prescription drugs, generate more pharmaceutical profits, and fatten up their own bank accounts with huge deposits of cash.